SBC Medical Group Holdings ISBC
13F holders, Q1 2025 (March 31)4holders
1new positions
1sold out
$3.19avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding SBC Medical Group Holdings I (SBC) in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were UBS Group AG ($196K), SBI Securities Co., Ltd. ($53K) and Marshall Wace, LLP ($37K).
- Company
- SBC Medical Group Holdings I
- CUSIP
- 73245B107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $37K |
| Exits | 1 | $117 |
All 13F filers, Q4 2024 → Q1 2025: 59,181 shares bought and 21 shares sold, net +59,160 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| UBS Group AG | 0.00% | Add +158.4% | 61,343 | $196K |
| SBI Securities Co., Ltd. | 0.00% | Add +156.2% | 16,554 | $53K |
| Marshall Wace, LLP | 0.00% | New | 11,485 | $37K |
| Morgan Stanley | 0.00% | No change | 900 | $3K |
"% of holder's portfolio" is SBC's weight in each manager's 13F, not the share of SBC Medical Group Holdings I the manager owns.